Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema
Purpose: To report the efficacy and safety of interferon alpha 2b in the treatment of pseudophakic cystoid macular edema resistant to conventional therapy. Observations: A 64-year-old patient presented with pseudophakic cystoid macular edema in her left eye, which developed two months after an uncom...
Main Authors: | Arash Maleki, Hossein Aghaei, Stacey Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | American Journal of Ophthalmology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993617303328 |
Similar Items
-
Improvement of pseudophakic cystoid macular edema with subconjunctival injections of interferon α2b:a case report
by: Hossein Aghaei, et al.
Published: (2022-06-01) -
Topical three-drug combination in the management of pseudophakic cystoid macular edema
by: Siddharth Sane, et al.
Published: (2024-09-01) -
Pseudophakic cystoid macular edema: update 2016
by: Grzybowski A, et al.
Published: (2016-09-01) -
Topical Interferon Alpha 2b in the Treatment of Refractory Diabetic Macular Edema
by: Arash Maleki, et al.
Published: (2020-10-01) -
Anti-interleukin-6 receptor therapy with tocilizumab for refractory pseudophakic cystoid macular edema
by: Brandon Huy Pham, et al.
Published: (2020-12-01)